1. Home
  2. XOMAP
  3. XOMAP News

Latest XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock (XOMAP) News on September 5, 2025

XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?
XOMAP

Zacks

2 months ago

XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?

XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMAP

GlobeNewswire

3 months ago

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
XOMAP

GlobeNewswire

3 months ago

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

XOMAP

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 05/21/2025

Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
XOMAP

Simply Wall St.

4 months ago

Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

XOMA Royalty First Quarter 2025 Earnings: Beats Expectations
XOMAP

Simply Wall St.

4 months ago

XOMA Royalty First Quarter 2025 Earnings: Beats Expectations

XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates
XOMAP

Zacks

4 months ago

XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates

XOMAP

Associated Press Finance

4 months ago

XOMA Royalty: Q1 Earnings Snapshot

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
XOMAP

GlobeNewswire

4 months ago

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
XOMAP

GlobeNewswire

4 months ago

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference

High Growth Tech Stocks In The US To Watch April 2025
XOMAP

Simply Wall St.

4 months ago

High Growth Tech Stocks In The US To Watch April 2025

XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability
XOMAP

Simply Wall St.

5 months ago

XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability

XOMA Royalty Completes Sale of Kinnate Pipeline Assets
XOMAP

GlobeNewswire

5 months ago

XOMA Royalty Completes Sale of Kinnate Pipeline Assets

XOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout
XOMAP

Insider Monkey

5 months ago

XOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout

XOMAP

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 04/09/2025

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
XOMAP

GlobeNewswire

5 months ago

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMAP

GlobeNewswire

6 months ago

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Full Year 2024 Earnings: EPS Misses Expectations
XOMAP

Simply Wall St.

6 months ago

XOMA Royalty Full Year 2024 Earnings: EPS Misses Expectations

XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements
XOMAP

GlobeNewswire

6 months ago

XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements

XOMA Royalty Corporation's (NASDAQ:XOMA) largest shareholders are retail investors with 38% ownership, institutions own 36%
XOMAP

Simply Wall St.

6 months ago

XOMA Royalty Corporation's (NASDAQ:XOMA) largest shareholders are retail investors with 38% ownership, institutions own 36%

XOMA Royalty to Present at Investor Conferences in March
XOMAP

GlobeNewswire

6 months ago

XOMA Royalty to Present at Investor Conferences in March

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
XOMAP

GlobeNewswire

7 months ago

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

XOMAP

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 01/29/2025

XOMAP

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 01/06/2025

XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMAP

GlobeNewswire

9 months ago

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMAP

MT Newswires

9 months ago

XOMA Royalty Acquires Pulmokine for $20 Million

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
XOMAP

GlobeNewswire

9 months ago

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

What Makes XOMA Royalty (XOMA) a New Buy Stock
XOMAP

Zacks

10 months ago

What Makes XOMA Royalty (XOMA) a New Buy Stock

XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
XOMAP

Simply Wall St.

10 months ago

XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
XOMAP

Simply Wall St.

10 months ago

XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates
XOMAP

Zacks

10 months ago

XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates

XOMAP

Associated Press Finance

10 months ago

XOMA Royalty: Q3 Earnings Snapshot

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
XOMAP

GlobeNewswire

10 months ago

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
XOMAP

GlobeNewswire

10 months ago

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year
XOMAP

Simply Wall St.

10 months ago

Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
XOMAP

GlobeNewswire

a year ago

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMAP

GlobeNewswire

a year ago

XOMA Royalty Declares Quarterly Preferred Stock Dividends

High Growth Tech Stocks In The United States To Watch
XOMAP

Simply Wall St.

a year ago

High Growth Tech Stocks In The United States To Watch

XOMA Royalty to Present at Upcoming Investor Conferences in September
XOMAP

GlobeNewswire

a year ago

XOMA Royalty to Present at Upcoming Investor Conferences in September

Party Time: Brokers Just Made Major Increases To Their XOMA Royalty Corporation (NASDAQ:XOMA) Earnings Forecasts
XOMAP

Simply Wall St.

a year ago

Party Time: Brokers Just Made Major Increases To Their XOMA Royalty Corporation (NASDAQ:XOMA) Earnings Forecasts

XOMA Royalty Second Quarter 2024 Earnings: Beats Expectations
XOMAP

Simply Wall St.

a year ago

XOMA Royalty Second Quarter 2024 Earnings: Beats Expectations

XOMA Royalty (XOMA) Reports Q2 Loss, Tops Revenue Estimates
XOMAP

Zacks

a year ago

XOMA Royalty (XOMA) Reports Q2 Loss, Tops Revenue Estimates

XOMAP

Associated Press Finance

a year ago

XOMA Royalty: Q2 Earnings Snapshot

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities
XOMAP

GlobeNewswire

a year ago

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities

ITeos Therapeutics, Inc. (ITOS) Reports Q2 Loss, Tops Revenue Estimates
XOMAP

Zacks

a year ago

ITeos Therapeutics, Inc. (ITOS) Reports Q2 Loss, Tops Revenue Estimates

Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?
XOMAP

Zacks

a year ago

Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?

XOMA Corporation's (NASDAQ:XOMA) institutional investors lost 11% last week but have benefitted from longer-term gains
XOMAP

Simply Wall St.

a year ago

XOMA Corporation's (NASDAQ:XOMA) institutional investors lost 11% last week but have benefitted from longer-term gains

Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?
XOMAP

Zacks

a year ago

Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?

XOMA Declares Quarterly Preferred Stock Dividends
XOMAP

GlobeNewswire

a year ago

XOMA Declares Quarterly Preferred Stock Dividends

XOMAP

MT Newswires

a year ago

XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
XOMAP

GlobeNewswire

a year ago

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
XOMAP

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

XOMAP

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
XOMAP

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

XOMAP

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
XOMAP

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
XOMAP

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
XOMAP

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
XOMAP

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

XOMAP

Journal-News, Hamilton, Ohio

a year ago

Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs
XOMAP

TechCrunch

a year ago

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now
XOMAP

Motley Fool

a year ago

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Italian energy company targets Britain for fleet of 20 mini-nukes
XOMAP

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
XOMAP

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Saudis Said to Hand About 60% of Aramco Offer to Foreigners
XOMAP

Bloomberg

a year ago

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
XOMAP

Simply Wall St.

a year ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
XOMAP

Simply Wall St.

a year ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
XOMAP

GlobeNewswire

a year ago

XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ

XOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net Loss
XOMAP

GuruFocus.com

a year ago

XOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net Loss

XOMAP

Associated Press Finance

a year ago

Xoma: Q1 Earnings Snapshot

XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
XOMAP

GlobeNewswire

a year ago

XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities

Certara, Inc. (CERT) Q1 Earnings Meet Estimates
XOMAP

Zacks

a year ago

Certara, Inc. (CERT) Q1 Earnings Meet Estimates

Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
XOMAP

Zacks

a year ago

Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
XOMAP

GlobeNewswire

a year ago

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
XOMAP

GlobeNewswire

a year ago

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)

Actym Therapeutics Appoints Thomas Smart as CEO
XOMAP

PR Newswire

a year ago

Actym Therapeutics Appoints Thomas Smart as CEO

XOMA (NASDAQ:XOMA) shareholders have earned a 16% CAGR over the last five years
XOMAP

Simply Wall St.

a year ago

XOMA (NASDAQ:XOMA) shareholders have earned a 16% CAGR over the last five years

XOMA Corporation Announces Closing of Tender Offer
XOMAP

GlobeNewswire

a year ago

XOMA Corporation Announces Closing of Tender Offer

XOMA Declares Quarterly Preferred Stock Dividends
XOMAP

GlobeNewswire

a year ago

XOMA Declares Quarterly Preferred Stock Dividends

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
XOMAP

GlobeNewswire

a year ago

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.

XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023
XOMAP

GuruFocus.com

a year ago

XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023

XOMAP

Associated Press Finance

a year ago

Xoma: Q4 Earnings Snapshot

XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
XOMAP

GlobeNewswire

a year ago

XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value

XOMA to Present at Upcoming Investor Conferences in March
XOMAP

GlobeNewswire

2 years ago

XOMA to Present at Upcoming Investor Conferences in March

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
XOMAP

GlobeNewswire

2 years ago

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right

SEALSQ to Hold its First Analyst & Investor Day on April 1, 2024 in New York City
XOMAP

GlobeNewswire

2 years ago

SEALSQ to Hold its First Analyst & Investor Day on April 1, 2024 in New York City

WallachBeth Capital Announce Closing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering
XOMAP

PR Newswire

2 years ago

WallachBeth Capital Announce Closing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
XOMAP

GlobeNewswire

2 years ago

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering

Palisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million
XOMAP

GlobeNewswire

2 years ago

Palisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million

RELI Exchange Launches the Client Referral Portal into its Proprietary InsurTech Platform
XOMAP

GlobeNewswire

2 years ago

RELI Exchange Launches the Client Referral Portal into its Proprietary InsurTech Platform

Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn’s & Colitis Congress
XOMAP

GlobeNewswire

2 years ago

Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn’s & Colitis Congress

Ribbon Honored with "Rise and Shine" Award from MTN GSSC - Global Sourcing and Supply Chain
XOMAP

CNW Group

2 years ago

Ribbon Honored with "Rise and Shine" Award from MTN GSSC - Global Sourcing and Supply Chain

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
XOMAP

PR Newswire

2 years ago

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Sphere 3D Announces Agreement with Core Scientific
XOMAP

Newsfile

2 years ago

Sphere 3D Announces Agreement with Core Scientific

NVE Corporation (NASDAQ:NVEC) Will Pay A US$1.00 Dividend In Four Days
XOMAP

Simply Wall St.

2 years ago

NVE Corporation (NASDAQ:NVEC) Will Pay A US$1.00 Dividend In Four Days

With 37% ownership, XOMA Corporation (NASDAQ:XOMA) has piqued the interest of institutional investors
XOMAP

Simply Wall St.

2 years ago

With 37% ownership, XOMA Corporation (NASDAQ:XOMA) has piqued the interest of institutional investors

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT
XOMAP

Business Wire

2 years ago

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT

Doherty Enterprises Inc. Expands Restaurant Portfolio in New York with Acquisition of 21 Applebee's® Restaurants formerly owned by Apple Metro
XOMAP

PR Newswire

2 years ago

Doherty Enterprises Inc. Expands Restaurant Portfolio in New York with Acquisition of 21 Applebee's® Restaurants formerly owned by Apple Metro

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition
XOMAP

GlobeNewswire

2 years ago

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition

D-Wave to Participate in 26th Annual Needham Growth Conference
XOMAP

Business Wire

2 years ago

D-Wave to Participate in 26th Annual Needham Growth Conference

Share on Social Networks: